These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38990560)

  • 1. Congress Must Update FDA Regulations for Medical AI.
    Gottlieb S
    JAMA Health Forum; 2024 Jul; 5(7):e242691. PubMed ID: 38990560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing health disparities in the Food and Drug Administration's artificial intelligence and machine learning regulatory framework.
    Ferryman K
    J Am Med Inform Assoc; 2020 Dec; 27(12):2016-2019. PubMed ID: 32951036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concepts in U.S. Food and Drug Administration Regulation of Artificial Intelligence for Medical Imaging.
    Kohli A; Mahajan V; Seals K; Kohli A; Jha S
    AJR Am J Roentgenol; 2019 Oct; 213(4):886-888. PubMed ID: 31166758
    [No Abstract]   [Full Text] [Related]  

  • 4. The US Congress is taking on AI - this computer scientist is helping.
    Jones N
    Nature; 2024 May; 629(8013):738-739. PubMed ID: 38724662
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA-cleared artificial intelligence and machine learning-based medical devices and their 510(k) predicate networks.
    Muehlematter UJ; Bluethgen C; Vokinger KN
    Lancet Digit Health; 2023 Sep; 5(9):e618-e626. PubMed ID: 37625896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conflicting information from the Food and Drug Administration: Missed opportunity to lead standards for safe and effective medical artificial intelligence solutions.
    Hernandez-Boussard T; Lundgren MP; Shah N
    J Am Med Inform Assoc; 2021 Jun; 28(6):1353-1355. PubMed ID: 33674865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marketing and US Food and Drug Administration Clearance of Artificial Intelligence and Machine Learning Enabled Software in and as Medical Devices: A Systematic Review.
    Clark P; Kim J; Aphinyanaphongs Y
    JAMA Netw Open; 2023 Jul; 6(7):e2321792. PubMed ID: 37405771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015-20): a comparative analysis.
    Muehlematter UJ; Daniore P; Vokinger KN
    Lancet Digit Health; 2021 Mar; 3(3):e195-e203. PubMed ID: 33478929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiology in 2018: Are You Working with AI or Being Replaced by AI?
    Bluemke DA
    Radiology; 2018 May; 287(2):365-366. PubMed ID: 29668407
    [No Abstract]   [Full Text] [Related]  

  • 10. The regulatory environment for artificial intelligence-enabled devices in the United States.
    Liang NL; Chung TK; Vorp DA
    Semin Vasc Surg; 2023 Sep; 36(3):435-439. PubMed ID: 37863617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Healthcare data and artificial intelligence: a geostrategic vision].
    Parmentier F
    Soins; 2019 Sep; 64(838):53-55. PubMed ID: 31542124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA Regulation and Approval of Medical Devices: 1976-2020.
    Darrow JJ; Avorn J; Kesselheim AS
    JAMA; 2021 Aug; 326(5):420-432. PubMed ID: 34342614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in clinical validation and usage of US Food and Drug Administration-cleared artificial intelligence algorithms for medical imaging.
    Khunte M; Chae A; Wang R; Jain R; Sun Y; Sollee JR; Jiao Z; Bai HX
    Clin Radiol; 2023 Feb; 78(2):123-129. PubMed ID: 36625218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial Intelligence in Emergency Medicine: Surmountable Barriers With Revolutionary Potential.
    Grant K; McParland A; Mehta S; Ackery AD
    Ann Emerg Med; 2020 Jun; 75(6):721-726. PubMed ID: 32093974
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulatory Issues and Challenges to Artificial Intelligence Adoption.
    Harvey HB; Gowda V
    Radiol Clin North Am; 2021 Nov; 59(6):1075-1083. PubMed ID: 34689875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The next forum for unraveling FDA off-label marketing rules: State and federal legislatures.
    Sinha MS; Kesselheim AS
    PLoS Med; 2018 May; 15(5):e1002564. PubMed ID: 29738523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How the FDA Regulates AI.
    Harvey HB; Gowda V
    Acad Radiol; 2020 Jan; 27(1):58-61. PubMed ID: 31818387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2021 landscape of FDA-approved artificial intelligence/machine learning-enabled medical devices: An analysis of the characteristics and intended use.
    Zhu S; Gilbert M; Chetty I; Siddiqui F
    Int J Med Inform; 2022 Sep; 165():104828. PubMed ID: 35780651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA regulation of human cloning: usurpation or statesmanship?
    Merrill RA; Rose BJ
    Harv J Law Technol; 2001; 15(1):85-148. PubMed ID: 15156886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.